Login / Signup

Reducing Kidney Disease Burden in Type 2 Diabetes with SGLT2 Inhibitors: Shifting the Goalposts Upstream.

Janani RangaswamiRoy O Mathew
Published in: Clinical journal of the American Society of Nephrology : CJASN (2023)
Keyphrases
  • type diabetes
  • glycemic control
  • cardiovascular disease
  • insulin resistance
  • risk factors
  • adipose tissue
  • weight loss